Total Payments
$7,043
2024 Payments
$980.35
Companies
29
Transactions
230
Medicare Patients
6,095
Medicare Billing
$717,866
Payment Breakdown by Category
Food & Beverage$6,903 (98.0%)
Education$140.30 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,903 | 222 | 98.0% |
| Education | $140.30 | 8 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,883 | 108 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,356 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $550.17 | 11 | $0 (2024) |
| Allergan, Inc. | $446.48 | 21 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $364.99 | 3 | $0 (2022) |
| Amarin Pharma Inc. | $209.51 | 11 | $0 (2021) |
| Ironwood Pharmaceuticals, Inc | $178.13 | 5 | $0 (2023) |
| PFIZER INC. | $133.10 | 2 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $120.30 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $101.18 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $980.35 | 27 | AstraZeneca Pharmaceuticals LP ($409.31) |
| 2023 | $836.93 | 36 | ABBVIE INC. ($443.56) |
| 2022 | $1,592 | 43 | ABBVIE INC. ($930.20) |
| 2021 | $1,156 | 37 | AbbVie Inc. ($709.35) |
| 2020 | $443.66 | 20 | AstraZeneca Pharmaceuticals LP ($249.16) |
| 2019 | $1,056 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($240.01) |
| 2018 | $230.81 | 19 | Allergan Inc. ($68.61) |
| 2017 | $747.57 | 28 | Allergan Inc. ($169.39) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/27/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.37 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $120.30 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/14/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $122.45 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Respiratory | ||||||
| 04/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/12/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $32.67 | General |
| 04/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Respiratory | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Respiratory | ||||||
| 02/23/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Respiratory | ||||||
| 02/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,502 | 3,157 | $298,228 | $178,336 |
| 2022 | 15 | 1,709 | 3,941 | $341,417 | $204,828 |
| 2021 | 13 | 1,558 | 3,984 | $307,675 | $201,727 |
| 2020 | 11 | 1,326 | 3,076 | $198,946 | $132,976 |
Total Patients
6,095
Total Services
14,158
Medicare Billing
$717,866
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 952 | $116,224 | $72,529 | 62.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 188 | 188 | $31,394 | $27,252 | 86.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 223 | 661 | $52,906 | $19,070 | 36.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 168 | 331 | $25,168 | $16,594 | 65.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 129 | $21,335 | $13,198 | 61.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 86 | 141 | $11,877 | $6,782 | 57.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 21 | $7,150 | $5,250 | 73.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 88 | 91 | $3,185 | $3,091 | 97.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 15 | $3,772 | $2,769 | 73.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 49 | 77 | $4,620 | $2,574 | 55.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 93 | 93 | $2,335 | $1,982 | 84.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 88 | 91 | $4,570 | $1,861 | 40.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 133 | $4,836 | $1,678 | 34.7% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 14 | 20 | $2,020 | $1,502 | 74.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 25 | $2,829 | $1,367 | 48.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 48 | 59 | $1,397 | $683.80 | 48.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 44 | 130 | $2,610 | $151.76 | 5.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 241 | 865 | $106,568 | $65,412 | 61.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 202 | 654 | $46,310 | $36,094 | 77.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 196 | 196 | $31,186 | $28,843 | 92.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 233 | 692 | $55,387 | $20,869 | 37.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 215 | 337 | $28,375 | $15,274 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 123 | $20,428 | $13,796 | 67.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 85 | 166 | $18,788 | $8,547 | 45.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 19 | 19 | $3,954 | $3,599 | 91.0% |
About Dr. Nina Logvinenko, M.D
Dr. Nina Logvinenko, M.D is a Internal Medicine healthcare provider based in Fair Lawn, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275570335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nina Logvinenko, M.D has received a total of $7,043 in payments from pharmaceutical and medical device companies, with $980.35 received in 2024. These payments were reported across 230 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,903).
As a Medicare-enrolled provider, Logvinenko has provided services to 6,095 Medicare beneficiaries, totaling 14,158 services with total Medicare billing of $717,866. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fair Lawn, NJ
- Active Since 05/31/2006
- Last Updated 11/23/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275570335
Products in Payments
- FARXIGA (Drug) $821.83
- VRAYLAR (Drug) $654.34
- LINZESS (Drug) $533.90
- BOTOX (Biological) $424.68
- QULIPTA (Drug) $417.39
- JARDIANCE (Drug) $397.14
- UBRELVY (Drug) $388.87
- AIRSUPRA (Drug) $287.46
- BREZTRI (Drug) $246.83
- Creon (Drug) $235.27
- CREON (Drug) $213.94
- Vascepa (Drug) $209.51
- NUCALA (Biological) $205.68
- TRELEGY ELLIPTA (Drug) $170.87
- Linzess (Drug) $153.72
- Qelbree (Drug) $120.30
- EUCRISA (Drug) $114.19
- XIFAXAN (Drug) $105.54
- NAMZARIC (Drug) $100.63
- INVOKANA (Drug) $71.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fair Lawn
Joshua Balog, M.d, M.D
Internal Medicine — Payments: $17,629
Internal Medicine $17,629
Dr. Walid Elkhalili, Md, MD
Internal Medicine — Payments: $16,179
Internal Medicine $16,179
Dr. Nina Safa, Md, MD
Internal Medicine — Payments: $10,848
Internal Medicine $10,848
Mira Upadhyaya, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $9,548
Internal Medicine $9,548
Dr. Mark Reyn, Md, MD
Internal Medicine — Payments: $8,475
Internal Medicine $8,475
Dr. Basel Batarseh, Md, MD
Internal Medicine — Payments: $7,812
Internal Medicine $7,812